Effectiveness of inhaled aromatherapy on chemotherapy-induced nausea and vomiting: a systematic review

J Toniolo, V Delaide, P Beloni - The Journal of Alternative and …, 2021 - liebertpub.com
Background: Chemotherapy-induced nausea and vomiting (CINV) are among the most
common and feared side effects of cancer treatments. Their presence has a negative impact …

[HTML][HTML] Tisotumab vedotin safety and tolerability in clinical practice: managing adverse events

CR Arn, KJ Halla, S Gill - Journal of the Advanced Practitioner in …, 2023 - ncbi.nlm.nih.gov
Tisotumab vedotin-tftv, an antibody-drug conjugate indicated for the treatment of adult
patients with recurrent or metastatic cervical cancer with disease progression on or after …

Practice patterns for prevention of chemotherapy-induced nausea and vomiting and antiemetic guideline adherence based on real-world prescribing data

M Aapro, F Scotté, Y Escobar, L Celio, R Berman… - The …, 2021 - academic.oup.com
Background Guideline-recommended antiemetic prophylaxis improves nausea and vomiting
control in most patients undergoing chemotherapy. Multinational Association of Supportive …

[HTML][HTML] Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: results of the nausea/emesis registry …

M Aapro, Z Caprariu, P Chilingirov, M Chrápavá… - European Journal of …, 2022 - Elsevier
Background Evidence-based antiemetic guidelines offer predominantly consistent
recommendations for chemotherapy-induced nausea and vomiting (CINV) prophylaxis …

Real-world evidence of NEPA, netupitant-palonosetron, in chemotherapy-induced nausea and vomiting prevention: effects on quality of life

M Karthaus, G Oskay-Özcelik, P Wülfing… - Future …, 2020 - Taylor & Francis
Aim: To determine quality of life, effectiveness and safety of oral netupitant-palonosetron
(NEPA)–based antiemetic prophylaxis in the real-world setting. Materials & methods …

[HTML][HTML] Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting: from clinical trials to daily practice

M Aapro, K Jordan, F Scotté, L Celio… - Current Cancer Drug …, 2022 - ncbi.nlm.nih.gov
Chemotherapy-induced nausea and vomiting (CINV) is a common adverse event associated
with many anticancer therapies and can negatively impact patients' quality of life and …

Phase IIIb safety and efficacy of intravenous NEPA for prevention of chemotherapy‐induced nausea and vomiting (CINV) in patients with breast cancer receiving initial …

L Schwartzberg, R Navari, R Clark‐Snow… - The …, 2020 - academic.oup.com
Background NEPA, a combination antiemetic of a neurokinin‐1 (NK1) receptor antagonist
(RA)(netupitant [oral]/fosnetupitant [intravenous; IV]) and 5‐HT3RA, palonosetron] offers 5 …

Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults

M Karthaus, X Schiel, CH Ruhlmann… - Expert review of clinical …, 2019 - Taylor & Francis
Introduction: The addition of neurokinin-1 receptor antagonists (NK1RAs) to standard
prophylaxis of 5-hydroxytryptamine-3 RA (5-HT3RA) plus dexamethasone more effectively …

Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: a randomized multicenter trial

A Antonuzzo, CI Ripamonti, F Roila, A Sbrana… - Frontiers in …, 2022 - frontiersin.org
Purpose Anticancer treatment-related toxicities can impact morbidity and mortality, hamper
the administration of treatment, worsen the quality of life and increase the burden on the …

Effect of Abdominal Massage with and without Salvia officinalis on Nausea and Vomiting in Patients with Cancer Undergoing Chemotherapy: A Randomized Clinical …

F Rafiee Sarbijan Nasab… - Journal of …, 2021 - Wiley Online Library
Objective. The aim of this study was to determine the effect of abdominal massage with and
without Salvia officinalis on nausea and vomiting in patients with cancer undergoing …